You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence

New view of stomach cancer could hasten better therapies

July 23, 2014

In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers from Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities.

Magnet Logo 

DF/BWCC Named One of "100 Hospitals with Great Oncology Programs"

July 23, 2014

Becker's Hospital Review has named Dana-Farber/Brigham and Women's Cancer Center to its 2014 "100 Hospitals and Health Systems with Great Oncology Programs." Becker's annual list recognizes hospitals that are leaders in cancer research, outcomes, and quality patient care.
 

Matthew Meyerson, MD, PhD in the lab 

Nineteen Dana-Farber scientists listed among world's most influential

July 01, 2014

In an affirmation of worldwide respect for the impact of Dana-Farber research, 19 basic scientists and clinical investigators at the Institute have been listed among "the world's most influential scientific minds." The ranking was based on how frequently their research discoveries have been cited by peers in the past decade.
 

Dana-Farber Cancer Institute recognized as a Magnet® organization for excellence in nursing and patient care
July 16, 2014

Dana-Farber Cancer Institute is recognized as a Magnet® organization for excellence in nursing and patient care for the third time.

U.S. News and World Report ranks Dana-Farber/Brigham and Women’s Cancer Center the top cancer hospital in New England; fourth in U.S.
July 15, 2014

U.S. News and World Report ranks Dana-Farber/Brigham and Women's Cancer Center the top hospital in New England for the 14th straight year.

Antibody halts cancer-related wasting condition
July 13, 2014

Dana-Farber scientists identify a protein that is a cause of cachexia, a severe wasting of fat and muscle in half of all cancer patients, and show that blocking the protein in mice can prevent or halt the debilitating condition.

Fresh Concerns About a Hysterectomy Procedure Linked to Cancer Spread (New York Times)

July 23, 2014

Dr. Suzanne George commented on a study showing that undetected tumors in women having hysterectomies are more common than many experts had thought, a conclusion that is fueling calls to limit or eliminate a particular hysterectomy procedure.

100 Hospitals and Health Systems With Great Oncology Programs (Becker's Hospital Review)
July 22, 2014

Becker's Hospital Review named Dana-Farber/Brigham and Women's Cancer Center to the 2014 edition of "100 Hospitals and Health Systems With Great Oncology Programs."

U.S. News & World Report Announces 2014-15 Best Hospitals Rankings (U.S. News & World Report)
July 15, 2014

The U.S. News and World Report Best Hospitals Guide has ranked Dana-Farber/Brigham and Women's Cancer Center the highest in New England for cancer care for the 14th straight year and fourth overall in the country.

Study Discounts Testosterone Therapy for Early Prostate Cancer (The New York Times)
July 14, 2014

An editorial written by physicians at Dana-Farber supports a study showing there is no compelling evidence to justify using testosterone suppression therapy on men with early-stage prostate cancer.

Ado-Trastuzumab Emtansine Improves Progression-Free Survival vs Physician’s Choice in Advanced HER2-Positive Breast Cancer (ASCO Post)
July 10, 2014

Dr. Ian E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine significantly prolonged progression-free survival in patients with progressive HER2-positive advanced breast cancer.

ASCO Clinical Practice Guideline: Disease Management in Advanced HER2-Positive Breast Cancer With Brain Metastases (ASCO Post)
July 10, 2014

Dr. Eric P. Winer co-chaired an expert panel that developed a clinical practice guideline on disease management for patients with advanced HER2-positive breast cancer and brain metastases.

Scientists publish a deep look at DNA mutations in lung cancer (Boston Globe)
July 10, 2014

Dr. Matthew Meyerson led a genomic study of lung cancer which has provided information that could help scientists devise new treatments.

Vote for Your Favorite Red Sox Star for the Chance to Win a Signed Jon Lester Jersey

July 24, 2014

Online

For over 60 years the Red Sox have had a special bond with the Jimmy Fund and Dana-Farber. Dating from 1953, this is the longest and most successful partnership between a professional sports team and charity in North America. The Red Sox have helped the Jimmy fund raise millions of dollars for cancer care and research at Dana-Farber through appearances and appeals while befriending patients of all ages. In honor of this partnership we are giving away a signed Jon Lester jersey to one lucky fan.  Just vote for your favorite Red Sox star here to be entered to win. Contest ends at 11:59pm on Tuesday, August 12. more

Free skin cancer education and screening at area beaches

July 24, 2014

11:00 AM - 3:00 PM

DCR Nantasket Beach, Hull, MA

Committed to the communities we serve, the Dana-Farber Cancer Institute's Blum Van will be visiting beaches across Massachusetts to provide free skin cancer education and screenings. A dermatologist will be on board to provide free full-body examinations and address any skin cancer related concerns. Participants will receive educational materials, sunscreen, key chains with energy beads that change color in response to UV rays, and Red Sox baseball caps.

Screenings may be cancelled if there is rain.  Call 617-632-2614 for more information!

more

Mindfulness Meditation(3)

July 24, 2014

11:30 AM - 1:00 PM

Smith 330, Stoneman Patient Services Suite

Presented by the Leonard P. Zakim Center for Integrative Therapies

Elana Rosenbaum, LICSW is a leader in the clinical application of mindfulness meditation to cancer care 

Join us for some mindfulness-based stress reduction and breath awareness. 

Adult patients, family members and caregivers are welcome. 

Registration required. For more information and to register, please contact the Zakim Center 

at 617-632-3322 or at Zakim_Center@dfci.harvard.edu

You may also visit us at Dana-Farber.com/Zakim.

more

  •  
  • Patient referral information, clinical resources and more.

  • Make an Appointment


    For adults:
    877-442-3324

    For children:
    888-733-4662


    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Dana-Farber Blog

    Insight Blog screenshot 

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now